NewsApril 26th, 2010admin
WILMINGTON, N.C., Apr 19, 2010 (GlobeNewswire via COMTEX) — TranS1 Inc. (TSON 3.45, +0.04, +1.17%) , a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, is pleased to announce the appointment of Joseph Slattery as Executive Vice President and Chief Financial Officer. In conjunction with his appointment, Mr. Slattery has resigned his position as a TranS1 Director and Chairman of the Audit Committee. More »
Joseph Slattery, Rick Randall, trans1